Anastrozole Pill

Phase 1Small molecule

MMassachusetts General Hospital

Anastrozole Pill is one of 68 small molecule programs targeting Metabolic Syndrome. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Metabolic SyndromeActive, not recruiting

Hypogonadotropic HypogonadismActive, not recruiting

Metabolic SyndromePhase 1

Active, not recruiting

Hypogonadotropic HypogonadismPhase 1

Active, not recruiting

Competition

Competitive Landscape

190 competitors in Metabolic Syndrome

#DrugCompanyPhaseTrials

Precose

Bayer

Phase 3

1 2

Zetia

OOrganon and Co

Phase 3

3 3

Jardiance

Boehringer Ingelheim

Phase 3

2 4

Topamax

WWim Janssens

Phase 3

1 5

Kineret

SSwedish Orphan Biovitrum

Phase 3

1 6

Genotropin

Rimonabant

Berberine

XXijing Hospital of Digestive Diseases

Phase 3

2 9

Pioglitazone and Insulin

Takeda

Phase 3

1 10

Nebido

Bayer

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Metabolic Syndrome1 trial

Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

Terminated·MMassachusetts General Hospital·Phase 1·NCT00438321·66 enrolled

Hypogonadotropic Hypogonadism1 trial

Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)

Terminated·MMassachusetts General Hospital·Phase 1·NCT03118479·7 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Anastrozole Pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Anastrozole Pill compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Anastrozole Pill. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Massachusetts General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: MMassachusetts General Hospital

Anastrozole Pill

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Metabolic Syndrome1 trial

Hypogonadotropic Hypogonadism1 trial

References

Drug Info

Quick Facts

Related News